(Total Views: 820)
Posted On: 06/20/2020 8:05:29 PM
Post# of 153908
If not $1000, what do you think it will be? I think $100 is too low. Given all the indication that Leron has and the potential revenue it can bring in, I wont be surprised if investors chase the stock to a PE of 40 or higher. With a 40 PE, all it takes is $2.5/share. If we use 800M shares, it is only $2B.
For $1000 we will need 20B with a PE of 40 and 40B with a PE of 20. Can Leron do it? HIV market will reach $40B by 2026 per research. Cancer Market size will reach $176B also by 2026. Not saying Leron can be effective with all Cancer but it could be effective on 23 of them. And per research, as high as 1/8 of American (not the world) may have NASH. How high can SP go? The more appropriate question is how many indication will work with Leron?
For $1000 we will need 20B with a PE of 40 and 40B with a PE of 20. Can Leron do it? HIV market will reach $40B by 2026 per research. Cancer Market size will reach $176B also by 2026. Not saying Leron can be effective with all Cancer but it could be effective on 23 of them. And per research, as high as 1/8 of American (not the world) may have NASH. How high can SP go? The more appropriate question is how many indication will work with Leron?
(3)
(0)
